Cerebrospinal fluid from 15 patients with ALS and 11 controls without neuro
logical disease were analysed for levels of the neurotrophic factors BDNF a
nd GDNF. Analyses were performed using a sensitive sandwich immunoassay (EL
ISA). There was no significant difference in BDNF levels between the ALS pa
tients and the control subjects studied. Measurable revels of GDNF were fou
nd in 12 out of 15 ALS samples. GDNF was not detected in CSF from any of th
e control subjects. The finding of increased CSF levels of GDNF in ALS comp
ared to controls, together with earlier findings of increased expression of
GDNF mRNA in muscle in ALS, indicates that the capacity to synthesize GDNF
is enhanced in this disorder. NeuroReport 11:1781-1783 (C) 2000 Lippincott
Williams & Wilkins.